학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 84건 | 목록 1~20
Editorial & Opinion
Serrano C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: cserrano@vhio.net.; Rothschild S; The Life Raft Group, Wayne, USA.; Villacampa G; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; The Institute of Cancer Research, London, UK.; Heinrich MC; Portland VA Health Care System and Knight Cancer Institute, Oregon Health & Science University, Portland.; George S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon; Université Claude Bernard, Lyon, France.; Sicklick JK; Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego; Department of Pharmacology, University of California San Diego, San Diego.; Schwartz GK; Case Comprehensive Cancer Center, Cleveland, USA.; Rastogi S; Department of Medical Oncology, AIIMS, New Delhi, India.; Jones RL; The Royal Marsden NHS Foundation Trust, London; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; Navarro V; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Evans D; The Life Raft Group, Wayne, USA.; Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Serrano C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: cserrano@vhio.net.; Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, DKTK-Partner-Site, University of Duisburg-Essen, Essen, Germany.; Gómez-Peregrina D; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Jones RL; Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Rutkowski P; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Mir O; Institut Gustave Roussy, Villejuif, France.; Heinrich MC; Portland VA Health Care System and OHSU Knight Cancer Institute, Portland.; Tap WD; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York.; Newberry K; Blueprint Medicines Corporation, Cambridge.; Grassian A; Blueprint Medicines Corporation, Cambridge.; Shi H; Blueprint Medicines Corporation, Cambridge.; Bialick S; Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.; Schöffski P; Department of General Medicine Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Pantaleo MA; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; von Mehren M; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia.; Trent JC; Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.; George S; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Boston, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Editorial & Opinion
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Print ISSN: 0007-1048 (Print) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Blanke CD; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University and Portland Veterans Affairs Medical Center, MC OP28, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201, USA. blankec@ohsu.edu; Eisenberg BLHeinrich MC
Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print Cited Medium: Print ISSN: 1527-2729 (Print) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE
Academic Journal
Dai MS; Department of Microbiology/Immunology and The Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202-5254, USA.; Heinrich MCBroxmeyer HELu L
Publisher: Martin Dunitz Ltd Country of Publication: England NLM ID: 9713367 Publication Model: Print Cited Medium: Print ISSN: 1368-4736 (Print) Linking ISSN: 13684736 NLM ISO Abbreviation: Cytokines Cell Mol Ther Subsets: MEDLINE
Academic Journal
Ben-Ami E; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston.; Barysauskas CM; Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston.; von Mehren M; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia.; Heinrich MC; VA Portland Health Care System and Oregon Health and Science University, Portland.; Corless CL; Oregon Health and Science University, Portland.; Butrynski JE; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston.; Morgan JA; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston.; Wagner AJ; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston.; Choy E; Division of Hematology Oncology, Massachusetts General Hospital, Boston.; Yap JT; Huntsman Cancer Institute, University of Utah, Salt Lake City Department of Radiology, University of Utah, Salt Lake City.; Van den Abbeele AD; Department of Imaging, Dana Farber Cancer Institute, Boston Department of Radiology.; Solomon SM; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston.; Fletcher JA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston.; Demetri GD; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston Department of Ludwig Center at Dana Farber/Harvard Cancer Center and Harvard Medical School, Boston, USA.; George S; Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston suzanne_george@dfci.harvard.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Heinrich, M C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어